We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Tenax Therapeutics
TENX
$385M
| $3.63M | ﹤0.01% |
298,153
+120,944
| +68% | +$1.05M |
|
1277
Philips
PHG
$25.4B
| $3.63M | ﹤0.01% |
+138,981
| New | +$3.71M |
|
|
BRCB
1278
Black Rock Coffee Bar Inc
BRCB
$170M
| $3.61M | ﹤0.01% |
162,247
+48,616
| +43% | +$1.13M |
|
1279
Public Storage
PSA
$60.2B
| $3.61M | ﹤0.01% |
13,911
-63,950
| -82% | -$17.9M |
|
1280
Teleflex
TFX
$5.85B
| $3.6M | ﹤0.01% |
29,527
-14,700
| -33% | -$1.78M |
|
1281
First Solar
FSLR
$21.8B
| $3.58M | ﹤0.01% |
13,721
-52,488
| -79% | -$13.2M |
|
1282
Align Technology
ALGN
$12B
| $3.58M | ﹤0.01% |
22,939
+14,011
| +157% | +$2.01M |
|
1283
Universal Health Services
UHS
$9.43B
| $3.57M | ﹤0.01% |
16,388
-100,170
| -86% | -$22.1M |
|
1284
LendingTree
TREE
$544M
| $3.57M | ﹤0.01% |
67,206
+5,846
| +10% | +$328K |
|
1285
New Oriental
EDU
$7.84B
| $3.56M | ﹤0.01% |
64,782
+52,392
| +423% | +$2.87M |
|
1286
Cognyte Software
CGNT
$612M
| $3.56M | ﹤0.01% |
378,893
-127,363
| -25% | -$1.1M |
|
1287
Valmont Industries
VMI
$9.44B
| $3.56M | ﹤0.01% |
8,840
-12,595
| -59% | -$5.13M |
|
1288
Liberty Broadband Class A
LBRDA
$4.14B
| $3.55M | ﹤0.01% |
73,603
-2,245
| -3% | -$116K |
|
1289
Kemper
KMPR
$1.7B
| $3.55M | ﹤0.01% |
+87,575
| New | +$3.75M |
|
1290
Procore
PCOR
$6.46B
| $3.54M | ﹤0.01% |
+48,685
| New | +$3.6M |
|
1291
Moderna
MRNA
$21.5B
| $3.52M | ﹤0.01% |
119,441
-145,932
| -55% | -$3.96M |
|
|
CIVI
1292
DELISTED
Civitas Resources
CIVI
| $3.52M | ﹤0.01% |
+129,954
| New | +$3.76M |
|
1293
Capricor Therapeutics
CAPR
$1.14B
| $3.52M | ﹤0.01% |
121,912
+22,799
| +23% | +$298K |
|
1294
Teekay Tankers
TNK
$2.63B
| $3.51M | ﹤0.01% |
65,751
-24,871
| -27% | -$1.4M |
|
1295
Bio-Rad Laboratories Class A
BIO
$8.42B
| $3.5M | ﹤0.01% |
11,560
-1,054
| -8% | -$329K |
|
1296
LPL Financial
LPLA
$26.3B
| $3.48M | ﹤0.01% |
9,744
-110,988
| -92% | -$39.3M |
|
1297
BrightView Holdings
BV
$1.31B
| $3.46M | ﹤0.01% |
273,388
+159,226
| +139% | +$2.02M |
|
1298
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
| $3.46M | ﹤0.01% |
+7,200
| New | +$3.41M |
|
|
OMDA
1299
Omada Health Inc
OMDA
$1.22B
| $3.44M | ﹤0.01% |
+218,126
| New | +$4.42M |
|
1300
Pinterest
PINS
$12.4B
| $3.44M | ﹤0.01% |
132,877
-6,468,358
| -98% | -$186M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.